Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis

被引:109
作者
Edwards, Robert R. [1 ,2 ]
Dolman, Andrew J. [1 ]
Martel, Marc O. [1 ]
Finan, Patrick H. [3 ]
Lazaridou, Asimina [1 ]
Cornelius, Marise [1 ]
Wasan, Ajay D. [1 ,4 ,5 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, 850 Boylston St,Suite 302, Chestnut Hill, MA 02467 USA
[2] Brigham & Womens Hosp, Pain Management Ctr, 850 Boylston St, Chestnut Hill, MA 02467 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat, 5510 Nathan Shock Dr,Suite 100, Baltimore, MD 21224 USA
[4] Univ Pittsburgh, Sch Med, Dept Anesthesiol, 400 Ctr Ave 400, Pittsburgh, PA 15206 USA
[5] Univ Pittsburgh, Sch Med, Dept Psychiat, 400 Ctr Ave 400, Pittsburgh, PA 15206 USA
关键词
Pain; Neuropathic; Osteoarthritis; NSAID; Diclofenac; Quantitative sensory testing; Conditioned pain modulation; CENTRAL SENSITIZATION; ABNORMALITIES; RELIABILITY; PERCEPTION; SUMMATION; SCORE;
D O I
10.1186/s12891-016-1124-6
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Background: Patients with painful knee osteoarthritis (OA) demonstrate hyperalgesia and altered pain-modulatory responses. While some prior work has demonstrated cross-sectional associations between laboratory and clinical pain measures, it is unknown whether individual variability in quantitative sensory testing (QST) responses at baseline can prospectively predict analgesic treatment responses. Method: Patients with knee OA (n = 35) were compared on QST responses to a demographically-matched pain-free control group (n = 39), after which patients completed a month-long treatment study of diclofenac sodium topical gel (1 %), applied up to 4 times daily. Results: OA patients demonstrated reduced pain thresholds at multiple anatomic sites, as well as reduced conditioned pain modulation (CPM) and enhanced temporal summation of pain. The most pain-sensitive patients tended to report the most intense and neuropathic OA pain. Following diclofenac treatment, the knee OA cohort showed a roughly 30 % improvement in pain, regardless of the presence or absence of neuropathic symptoms. Baseline CPM scores, an index of endogenous pain-inhibitory capacity, were prospectively associated with treatment-related changes in clinical pain. Specifically, participants with higher CPM at baseline (i.e., better functioning endogenous pain-inhibitory systems) showed more reduction in pain at the end of treatment (p < .05). Conclusions: These results support prior findings of amplified pain sensitivity and reduced pain-inhibition in OA patients. Moreover, the moderate to strong associations between laboratory-based measures of pain sensitivity and indices of clinical pain highlight the clinical relevance of QST in this sample. Finally, the prospective association between CPM and diclofenac response suggests that QST-based phenotyping may have utility in explaining inter-patient variability in long-term analgesic treatment outcomes.
引用
收藏
页数:9
相关论文
共 37 条
[1]
Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain [J].
Arendt-Nielsen, Lars ;
Skou, Soren T. ;
Nielsen, Thomas A. ;
Petersen, Kristian K. .
CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (04) :225-234
[2]
Experimental and Clinical Applications of Quantitative Sensory Testing Applied to Skin, Muscles and Viscera [J].
Arendt-Nielsen, Lars ;
Yarnitsky, David .
JOURNAL OF PAIN, 2009, 10 (06) :556-572
[3]
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus [J].
Backonja, Miroslav 'Misha'' ;
Attal, Nadine ;
Baron, Ralf ;
Bouhassira, Didier ;
Drangholt, Mark ;
Dyck, Peter J. ;
Edwards, Robert R. ;
Freeman, Roy ;
Gracely, Richard ;
Haanpaa, Maija H. ;
Hansson, Per ;
Hatem, Samar M. ;
Krumova, Elena K. ;
Jensen, Troels S. ;
Maier, Christoph ;
Mick, Gerard ;
Rice, Andrew S. ;
Rolke, Roman ;
Treede, Rolf-Detlef ;
Serra, Jordi ;
Toelle, Thomas ;
Tugnoli, Valeri ;
Walk, David ;
Walalce, Mark S. ;
Ware, Mark ;
Yarnitsky, David ;
Ziegler, Dan .
PAIN, 2013, 154 (09) :1807-1819
[4]
Banning M, 2008, EXPERT OPIN PHARMACO, V9, P2921, DOI [10.1517/14656566.9.16.2921, 10.1517/14656566.9.16.2921 ]
[5]
Banning Maggi, 2006, Br J Community Nurs, V11, P487
[6]
How to define responders in osteoarthritis [J].
Cooper, Cyrus ;
Adachi, Jonathan D. ;
Bardin, Thomas ;
Berenbaum, Francis ;
Flamion, Bruno ;
Jonsson, Helgi ;
Kanis, John A. ;
Pelousse, Franz ;
Lems, Willem F. ;
Pelletier, Jean-Pierre ;
Martel-Pelletier, Johanne ;
Reiter, Susanne ;
Reginster, Jean-Yves ;
Rizzoli, Rene ;
Bruyere, Olivier .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (06) :719-729
[7]
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study [J].
Cross, Marita ;
Smith, Emma ;
Hoy, Damian ;
Nolte, Sandra ;
Ackerman, Ilana ;
Fransen, Marlene ;
Bridgett, Lisa ;
Williams, Sean ;
Guillemin, Francis ;
Hill, Catherine L. ;
Laslett, Laura L. ;
Jones, Graeme ;
Cicuttini, Flavia M. ;
Osborne, Richard ;
Vos, Theo ;
Buchbinder, Rachelle ;
Woolf, Anthony ;
March, Lyn .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1323-1330
[8]
Can Quantitative Sensory Testing Move Us Closer to Mechanism-Based Pain Management? [J].
Cruz-Almeida, Yenisel ;
Fillingim, Roger B. .
PAIN MEDICINE, 2014, 15 (01) :61-72
[9]
Genetic basis for individual variations in pain perception and the development of a chronic pain condition [J].
Diatchenko, L ;
Slade, GD ;
Nackley, AG ;
Bhalang, K ;
Sigurdsson, A ;
Belfer, I ;
Goldman, D ;
Xu, K ;
Shabalina, SA ;
Shagin, D ;
Max, MB ;
Makarov, SS ;
Maixner, W .
HUMAN MOLECULAR GENETICS, 2005, 14 (01) :135-143
[10]
Selecting those to refer for joint replacement: Who will likely benefit and who will not? [J].
Dowsey, Michelle M. ;
Gunn, Jane ;
Choong, Peter F. M. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2014, 28 (01) :157-171